Cart
sales@molnova.com
Byakangelicin
CAS No. 19573-01-4
Byakangelicin( —— )
Catalog No. M18189 CAS No. 19573-01-4
Byakangelicin is an antineoplastic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 144 | In Stock |
|
| 25MG | 233 | In Stock |
|
| 50MG | 342 | In Stock |
|
| 100MG | 509 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameByakangelicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionByakangelicin is an antineoplastic agent.
-
DescriptionByakangelicin is an antineoplastic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19573-01-4
-
Formula Weight334.32
-
Molecular FormulaC17H18O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (299.11 mM)
-
SMILESCC(C)([C@@H](COc1c2c(c(c3c1oc(=O)cc3)OC)cco2)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yang J, et al. Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes. Br J Pharmacol. 2011 Jan;162(2):441-51.
molnova catalog
related products
-
PM 102
Peptide that reverses the anticoagulant effect of heparin. Potently binds heparin (Kd = 36 nM in vitro).
-
Deoxycholic acid
Extracted from Pig bile; Suitability:Ethanol,ether,three oxygen methane,acetone,acetic acid,alkali hydroxide and alkali carbonate solution;Store the product in sealed,cool and dry condition
-
LY-294002 hydrochlor...
LY294002 is a synthetic molecule inhibitor of PI3Kα/δ/β (IC50: 0.5/0.57/0.97 μM, in cell-free assays); more stable than Wortmannin in solution, and also is a blocker of autophagosome formation.
